Package 67296-2173-3

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 67296-2173-3
Digits Only 6729621733
Product NDC 67296-2173
Description

30 TABLET in 1 BOTTLE (67296-2173-3)

Marketing

Marketing Status
Marketed Since 2016-02-17
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBLINGUAL"], "spl_id": "44f7016d-6e09-106a-e063-6394a90a648b", "openfda": {"unii": ["56W8MW3EN1"], "rxcui": ["351265"], "spl_set_id": ["3dd00186-1f1f-642a-e063-6294a90a6d20"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67296-2173-3)", "package_ndc": "67296-2173-3", "marketing_start_date": "20160217"}], "brand_name": "Buprenorphine", "product_id": "67296-2173_44f7016d-6e09-106a-e063-6394a90a648b", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "67296-2173", "dea_schedule": "CIII", "generic_name": "Buprenorphine", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA201760", "marketing_category": "ANDA", "marketing_start_date": "20160217", "listing_expiration_date": "20261231"}